Ayman Elsayed Elfakharany  <br/><br/>
Treatment outcomes of diffuse large B-cell non-Hodgkins lymphoma presenting to Tanta cancer center /  
 نتائج علاج أورام الغدد الليمفاوية اللاهودجكنية المتسعة كبيرة الخلية من النوع باء في مركز أورام طنطا  
Ayman Elsayed Elfakharany ; Supervised Ahmed Abdelmabood Zeeneldin , Ayman Abdelsamie Gaber , Amgad Ahmad Shaheen  
 - Cairo :   Ayman Elsayed Elfakharany ,   2014 
 - 155 P. :   charts ;   25cm 
<br/><br/>Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Medical Oncology  
<br/><br/> Introduction: DLBC-NHL is the most common lymphoid neoplasm and constitutes almost 50% of all NHLs. Methods: This thesis includes 485 patients was conducted to study the outcomes in patients with DLBC-NHL among patients treated at Tanta Cancer Center (TCC) between 2003 and 2006 and followed up till March 2014. Results: 88% of patients received CTx being CHOP in 72.4% of cases. CR was achieved in 62.1%, PFS was 21.4 months. The median OS was 20 months. Conclusions: Outcomes of DBLC-NHL at TCC is comparable to those in the literature. Adding Rituximab is recommended to further improve the treatment 
<br/><br/>
<br/><br/><label>Subjects--Index Terms: </label>DLBC  Egyptian National Cancer Institute Tanta Cancer Center